Link Details
| ID: | 1843 |
| Title: | CuraGen And TopoTarget Initiate Phase I/II Clinical Trial Of Belinostat (PXD101) Combination Therapy - http://www.medicalnewstoday.com/articles/80885.php |
| Pagerank: | N/A |
| Description: | CuraGen Corporation (Nasdaq: CRGN) and TopoTarget A/S (Copenhagen Stock Exchange: TOPO) announced today the initiation of patient dosing in a Phase I/II clinical trial evaluating belinostat (PXD101), a histone deacetylase (HDAC) inhibitor, in combination with the anthracycline idarubicin for the treatment of Acute Myeloid Leukemia (AML). The trial is being conducted at multiple sites in the European Union. [click link for full article] |
| Category: | |
| Link Owner: | |
| Date Added: | August 29, 2007 07:00:00 AM |
| Number Hits: | 0 |